Evidence map›Paper›PMID 30357689›Full record

ReviewAdvances in experimental medicine and biology

Clinical Applications of Injectable Biomaterials.

Hatice Ercan, Serap Durkut, Aysel Koc-Demir, Ayşe Eser Elçin, Yaşar Murat Elçin

Abstract readReview
PubMed Publisher
In one paragraph

Review in Advances in experimental medicine and biology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Extracellular matrix grafts: From preparation to application (Review).International journal of molecular medicine · 2021
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hatice ErcanTissue Engineering, Biomaterials and Nanobiotechnology Laboratory, Faculty of Science, Stem Cell Institute, Ankara University, Ankara, Turkey.
Serap DurkutTissue Engineering, Biomaterials and Nanobiotechnology Laboratory, Faculty of Science, Stem Cell Institute, Ankara University, Ankara, Turkey.
Aysel Koc-DemirTissue Engineering, Biomaterials and Nanobiotechnology Laboratory, Faculty of Science, Stem Cell Institute, Ankara University, Ankara, Turkey.
Ayşe Eser ElçinTissue Engineering, Biomaterials and Nanobiotechnology Laboratory, Faculty of Science, Stem Cell Institute, Ankara University, Ankara, Turkey.
Yaşar Murat ElçinTissue Engineering, Biomaterials and Nanobiotechnology Laboratory, Faculty of Science, Stem Cell Institute, Ankara University, Ankara, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Regenerative medicine is an interdisciplinary field that aims to regenerate the lost or diseased tissues through the combinational use of cells, biomolecules and/or biomaterials. Injectable biomaterials have been comprehensively evaluated for use in this field for their prominent properties, such as ease of handling, providing a better integration of the native tissue by filling irregular defects and having controllable chemical and physical properties. This class of biomaterials can be developed from natural or synthetic origin materials, decellularized matrices or from combinations of materials to form composites. Injectable biomaterials enable minimally invasive approach when compared with traditional open surgeries, which can reduce the cost, and speed up the recovery time for the patients. Cells, growth factors and/or bioactive molecules can be effectively delivered to the target tissue using injectable biomaterials, making them desirable for a number of clinical applications. This chapter gives an overview on injectable biomaterials and their clinical applications in soft, hard, and cardiovascular tissue regeneration.

Indexed as

Biocompatible MaterialsHumansRegenerationRegenerative MedicineTissue EngineeringBiocompatible MaterialsBiopolymersClinical applicationsInjectable biomaterialsIn-situ gellingRegenerative medicineScaffoldsStimuli-responsive hydrogelsTissue engineering

Identifiers

PMID30357689

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.